These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11475441)

  • 1. Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination--possible markers for an antibody-mediated process.
    Brück W; Neubert K; Berger T; Weber JR
    Mult Scler; 2001 Jun; 7(3):173-7. PubMed ID: 11475441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations.
    Pittock SJ; Reindl M; Achenbach S; Berger T; Bruck W; Konig F; Morales Y; Lassmann H; Bryant S; Moore SB; Keegan BM; Lucchinetti CF
    Mult Scler; 2007 Jan; 13(1):7-16. PubMed ID: 17294606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H
    Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cells and antibodies in MS.
    Reindl M; Kuenz B; Berger T
    Results Probl Cell Differ; 2010; 51():99-113. PubMed ID: 19513636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.
    Rodriguez M
    Brain Pathol; 2007 Apr; 17(2):219-29. PubMed ID: 17388953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis.
    McFarland HI; Lobito AA; Johnson MM; Nyswaner JT; Frank JA; Palardy GR; Tresser N; Genain CP; Mueller JP; Matis LA; Lenardo MJ
    J Immunol; 1999 Feb; 162(4):2384-90. PubMed ID: 9973519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H
    Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological differences in acute inflammatory demyelinating diseases of the central nervous system.
    Wegner C
    Int MS J; 2005 Apr; 12(1):13-9, 12. PubMed ID: 15955274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic modalities in multiple sclerosis: perspectives in children.
    Chou IJ; Whitehouse WP; Wang HS; Tanasescu R; Constantinescu CS
    Biomed J; 2014; 37(2):50-9. PubMed ID: 24732659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS demyelination and quadrivalent HPV vaccination.
    Sutton I; Lahoria R; Tan I; Clouston P; Barnett M
    Mult Scler; 2009 Jan; 15(1):116-9. PubMed ID: 18805844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
    Vural A; Göçmen R; Kurne AT; Oğuz KK; Temuçin ÇM; Tan E; Karabudak R; Meinl E; Erdem Özdamar S
    Can J Neurol Sci; 2016 Jan; 43(1):149-56. PubMed ID: 26271726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology.
    Brück W; Bitsch A; Kolenda H; Brück Y; Stiefel M; Lassmann H
    Ann Neurol; 1997 Nov; 42(5):783-93. PubMed ID: 9392578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: pathologic, clinical, and imaging updates.
    Cook SD
    Rev Neurol Dis; 2006; 3(1):23-8. PubMed ID: 16596083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN; Snyder DS
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral mechanisms in immune neuropathies.
    Koski CL
    Neurol Clin; 1992 Aug; 10(3):629-49. PubMed ID: 1501599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein.
    Tatum AH
    Ann Neurol; 1993 May; 33(5):502-6. PubMed ID: 7684583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
    Quintana FJ; Patel B; Yeste A; Nyirenda M; Kenison J; Rahbari R; Fetco D; Hussain M; O'Mahony J; Magalhaes S; McGowan M; Johnson T; Rajasekharan S; Narayanan S; Arnold DL; Weiner HL; Banwell B; Bar-Or A;
    Neurology; 2014 Dec; 83(24):2219-26. PubMed ID: 25381299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive measurement of brain damage in a primate model of multiple sclerosis.
    't Hart BA; Vogels J; Bauer J; Brok HP; Blezer E
    Trends Mol Med; 2004 Feb; 10(2):85-91. PubMed ID: 15102362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.